 |
ganaxolone |
|---|---|
| Trade Name | |
| Orphan Indication | Cyclin-dependent kinase-like 5 (CDKL5) gene-related early-onset infantile epileptic encephalopathy |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-28 00:00:00 |
| Sponsor | Marinus Pharmaceuticals;170 North Radnor Chester Road, Suite 250;Radnor, Pennsylvania, 19087 |
